Atomistry » Sodium » PDB 3rnx-3si4 » 3s45
Atomistry »
  Sodium »
    PDB 3rnx-3si4 »
      3s45 »

Sodium in PDB 3s45: Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir

Enzymatic activity of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir

All present enzymatic activity of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir:
3.4.23.47;

Protein crystallography data

The structure of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir, PDB code: 3s45 was solved by Y.-F.Tie, Y.-F.Wang, I.T.Weber, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 10.00 / 1.51
Space group C 1 2 1
Cell size a, b, c (Å), α, β, γ (°) 105.998, 30.986, 56.161, 90.00, 91.66, 90.00
R / Rfree (%) 18.3 / 24.6

Other elements in 3s45:

The structure of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir also contains other interesting chemical elements:

Chlorine (Cl) 8 atoms
Zinc (Zn) 7 atoms

Sodium Binding Sites:

The binding sites of Sodium atom in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir (pdb code 3s45). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir, PDB code: 3s45:

Sodium binding site 1 out of 1 in 3s45

Go back to Sodium Binding Sites List in 3s45
Sodium binding site 1 out of 1 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Na501

b:38.9
occ:1.00
OD1 A:ASN41 2.1 20.3 1.0
O A:HOH1083 2.6 29.1 1.0
O A:HOH1054 3.0 23.6 1.0
CG A:ASN41 3.2 19.3 1.0
O A:ASN40 3.5 21.8 1.0
CA A:ASN41 3.5 19.0 1.0
CB A:ASN41 3.7 19.0 1.0
C A:ASN40 4.2 19.2 1.0
N A:ASN41 4.2 19.1 1.0
ND2 A:ASN41 4.3 26.9 1.0
C A:ASN41 4.7 17.2 1.0
O A:HOH1096 4.8 32.1 1.0
N A:TYR42 4.9 15.9 1.0

Reference:

Y.Tie, Y.F.Wang, P.I.Boross, T.Y.Chiu, A.K.Ghosh, J.Tozser, J.M.Louis, R.W.Harrison, I.T.Weber. Critical Differences in Hiv-1 and Hiv-2 Protease Specificity For Clinical Inhibitors. Protein Sci. V. 21 339 2012.
ISSN: ISSN 0961-8368
PubMed: 22238126
DOI: 10.1002/PRO.2019
Page generated: Tue Dec 15 06:24:22 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy